Unither Pharmaceuticals is an international contract development and manufacturing organisation (CDMO) focused on the production of liquid drug products, with particular expertise in sterile unit-dose formats. Headquartered in France, the company operates multiple manufacturing sites across Europe, the United States, Brazil, and China, supporting pharmaceutical and biotechnology clients worldwide.

Founded in 1993, Unither has built its capabilities around specialised drug delivery technologies, most notably blow-fill-seal (BFS) systems for sterile single-dose products. The company provides end-to-end services spanning formulation development, process development, and commercial-scale manufacturing, serving originator pharmaceutical companies, generics manufacturers, and over-the-counter product developers.

The organisation focuses on liquid dosage forms such as ophthalmic, respiratory, and oral solutions, as well as stick-pack and multi-dose formats. Its integrated model allows clients to progress from early-stage development through to regulatory-compliant commercial production using a single partner.

Unither is recognised for its scale in sterile unit-dose manufacturing, supported by high-capacity production infrastructure and continuous investment in specialised technologies. Its global footprint and technical expertise enable the company to support product development and supply across international markets.

Key products and services

• Contract development and manufacturing (CDMO) services for liquid drug products
• Sterile unit-dose manufacturing using blow-fill-seal (BFS) technology
• Non-sterile liquid formulations, including stick packs and multi-dose formats
• Drug product formulation and process development
• Analytical development, validation, and quality control
• Commercial-scale manufacturing and packaging services
• Development and manufacture of ophthalmic, respiratory, and oral liquid products
• Drug delivery technologies, including BFS and stick-pack systems

Unither Pharmaceuticals operates as a specialised CDMO with a strong focus on liquid dosage forms and single-dose delivery technologies. Its combination of development expertise, manufacturing scale, and global presence enables it to support pharmaceutical companies across the full product lifecycle, from early development through to commercial supply.